Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 129 (2), 522-527
- https://doi.org/10.1016/j.gastro.2005.05.008